Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia.
about
Reduced vancomycin susceptibility and staphylococcal cassette chromosome mec (SCCmec) type distribution in methicillin-resistant Staphylococcus aureus bacteraemia.Derivation and validation of clinical prediction rules for reduced vancomycin susceptibility in Staphylococcus aureus bacteraemia.Impact of Time to Appropriate Therapy on Mortality in Patients with Vancomycin-Intermediate Staphylococcus aureus Infection.Effects of vancomycin versus nafcillin in enhancing killing of methicillin-susceptible Staphylococcus aureus causing bacteremia by human cathelicidin LL-37.Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?
P2860
Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 December 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prior vancomycin use is a risk ...... phylococcus aureus bacteremia.
@en
Prior vancomycin use is a risk ...... phylococcus aureus bacteremia.
@nl
type
label
Prior vancomycin use is a risk ...... phylococcus aureus bacteremia.
@en
Prior vancomycin use is a risk ...... phylococcus aureus bacteremia.
@nl
prefLabel
Prior vancomycin use is a risk ...... phylococcus aureus bacteremia.
@en
Prior vancomycin use is a risk ...... phylococcus aureus bacteremia.
@nl
P2093
P2860
P356
P1476
Prior vancomycin use is a risk ...... aphylococcus aureus bacteremia
@en
P2093
Andrew J Baltus
Ebbing Lautenbach
Kara B Mascitti
Knashawn H Morales
Neil O Fishman
P2860
P304
P356
10.1086/663708
P577
2011-12-20T00:00:00Z